Asthma genetics and personalised medicine

The Lancet Respiratory Medicine

Volumn 2, Issue 5, 2014, Pages 405-415

  Meyers, Deborah A ^a   Bleecker, Eugene R ^a   Holloway, John W ^a   Holgate, Stephen T ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE DERIVATIVE; PITRAKINRA; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ASTHMA; BRONCHOCONSTRICTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; DRUG RESPONSE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; LUNG FUNCTION; PATHOGENESIS; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ASTHMA; GENE-ENVIRONMENT INTERACTION; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; PRECISION MEDICINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84900313699     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70012-8     Document Type: Review

References (88)

1. Genetic testing for cystic fibrosis. NIH Consens Statement 1997, 15:1-37. National Institutes of Health.
2. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
3. Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004, 364:1505-1512. for the National Heart, Lung, Blood Institute's Asthma Clinical Research NetworkBlood Institute's Asthma Clinical Research Network.
4. Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945. International Human Genome Sequencing Consortium.
5. A haplotype map of the human genome. Nature 2005, 437:1299-1320. International HapMap Consortium.
6. Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007, 448:470-473.
7. Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010, 363:1211-1221. for the GABRIEL Consortium.
8. Torgerson DG, Ampleford EJ, Chiu GY, et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011, 43:887-892.
9. Green ED, Guyer MS Charting a course for genomic medicine from base pairs to bedside. Nature 2011, 470:204-213. National Human Genome Research Institute.
10. Tantisira KG, Lasky-Su J, Harada M, et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med 2011, 365:1173-1183.
11. Li X, Ampleford EJ, Howard TD, et al. Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol 2012, 130:861-868. e7.
12. Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008, 358:910-919.
13. Thanassoulis G, Peloso GM, Pencina MJ, et al. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet 2012, 5:113-121.
14. Busse WW, Lemanske RF Asthma. N Engl J Med 2001, 344:350-362.
15. Difficult-to-treat severe asthma (European Respiratory Monograph 51) 2011, European Respiratory Society. K.F. Chung, E.H. Bel, S.E. Wenzel (Eds.).
16. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000, 162:2341-2351. American Thoracic Society.
17. Altshuler D, Daly MJ, Lander ES Genetic mapping in human disease. Science 2008, 322:881-888.
18. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008, 9:356-369.
19. Weiss ST, Raby BA, Rogers A Asthma genetics and genomics 2009. Curr Opin Genet Dev 2009, 19:279-282.
20. Holloway JW, Yang IA, Holgate ST Genetics of allergic disease. J Allergy Clin Immunol 2010, 125(suppl 2):S81-S94.
21. Wan YI, Shrine NR, Soler Artigas M, et al. Genome-wide association study to identify genetic determinants of severe asthma. Thorax 2012, 67:762-768.
22. Karunas AS, Iunusbaev BB, Fedorova IIu, et al. Genome-wide association study of bronchial asthma in the Volga-Ural region of Russia. Mol Biol (Mosk) 2011, 45:992-1003. (in Russian).
23. Sleiman PM, Flory J, Imielinski M, et al. Variants of DENND1B associated with asthma in children. N Engl J Med 2010, 362:36-44.
24. Ferreira MA, Matheson MC, Duffy DL, et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet 2011, 378:1006-1014. for the Australian Asthma Genetics Consortium.
25. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009, 41:342-347.
26. Li X, Howard TD, Zheng SL, et al. Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol 2010, 125:328-335. e11.
27. Noguchi E, Sakamoto H, Hirota T, et al. Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet 2011, 7:e1002170.
28. Park BL, Kim TH, Kim JH, et al. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet 2013, 132:313-321.
29. Lasky-Su J, Himes BE, Raby BA, et al. HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults. Clin Exp Allergy 2012, 42:1724-1733. for the SHARP investigators.
30. Hirota T, Takahashi A, Kubo M, et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 2011, 43:893-896.
31. Ramasamy A, Kuokkanen M, Vedantam S, et al. Genome-wide association studies of asthma in population-based cohorts confirm known and suggested loci and identify an additional association near HLA. PLoS One 2012, 7:e44008.
32. Himes BE, Hunninghake GM, Baurley JW, et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 2009, 84:581-593.
33. Narayan KMV, Weber MB Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2009, 360:1360.
34. Lötvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011, 127:355-360.
35. Schauberger EM, Ewart SL, Arshad SH, et al. Identification of ATPAF1 as a novel candidate gene for asthma in children. J Allergy Clin Immunol 2011, 128:753-760. e11.
36. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008, 178:218-224.
37. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010, 181:315-323. for the National Heart, Lung, Blood Institute's Severe Asthma Research ProgramBlood Institute's Severe Asthma Research Program.
38. Spycher BD, Henderson J, Granell R, et al. Genome-wide prediction of childhood asthma and related phenotypes in a longitudinal birth cohort. J Allergy Clin Immunol 2012, 130:503. 9.e7.
39. Lockett GA, Holloway JW Genome-wide association studies in asthma; perhaps, the end of the beginning. Curr Opin Allergy Clin Immunol 2013, 13:463-469.
40. Ege MJ, Strachan DP, Cookson WO, et al. Gene-environment interaction for childhood asthma and exposure to farming in Central Europe. J Allergy Clin Immunol 2011, 127:138-144. the GABRIELA Study Group, e1-4.
41. Cali{dotless}şkan M, Bochkov YA, Kreiner-Møller E, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013, 368:1398-1407.
42. Kauffmann F, Demenais F Gene-environment interactions in asthma and allergic diseases: challenges and perspectives. J Allergy Clin Immunol 2012, 130:1229-1240.
43. Rakyan VK, Down TA, Balding DJ, Beck S Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011, 12:529-541.
44. Relton CL, Davey Smith G Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol 2012, 41:161-176.
45. Karmaus W, Ziyab AH, Everson T, Holloway JW Epigenetic mechanisms and models in the origins of asthma. Curr Opin Allergy Clin Immunol 2013, 13:63-69.
46. Lockett GA, Patil VK, Soto-Ramírez N, Ziyab AH, Holloway JW, Karmaus W Epigenomics and allergic disease. Epigenomics 2013, 5:685-699.
47. Soto-Ramírez N, Arshad SH, Holloway JW, et al. The interaction of genetic variants and DNA methylation of the interleukin-4 receptor gene increase the risk of asthma at age 18 years. Clin Epigenetics 2013, 5:1.
48. Gerasimova A, Chavez L, Li B, et al. Predicting cell types and genetic variations contributing to disease by combining GWAS and epigenetic data. PLoS One 2013, 8:e54359.
49. Song GG, Lee YH Pathway analysis of genome-wide association study on asthma. Hum Immunol 2013, 74:256-260.
50. Himes BE, Sheppard K, Berndt A, et al. Integration of mouse and human genome-wide association data identifies KCNIP4 as an asthma gene. PLoS One 2013, 8:e56179.
51. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007, 119:405-413. for the National Heart, Lung, Blood Institute's Severe Asthma Research ProgramBlood Institute's Severe Asthma Research Program.
52. Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010, 42:45-52.
53. Postma DS, Brusselle G, Bush A, Holloway JW I have taken my umbrella, so of course it does not rain. Thorax 2012, 67:88-89.
54. Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010, 42:36-44.
55. Li X, Howard TD, Moore WC, et al. Importance of hedgehog interacting protein and other lung function genes in asthma. J Allergy Clin Immunol 2011, 127:1457-1465.
56. Li X, Hawkins GA, Ampleford EJ, et al. Genome-wide association study identifies Th1 pathway genes associated with lung function in asthmatic patients. J Allergy Clin Immunol 2013, 132:313-320. e15.
57. 358Ala is a potential modifier of lung function in subjects with asthma. J Allergy Clin Immunol 2012, 130:510-515. for the National Heart, Lung, Blood Institute-sponsored Severe Asthma Research Program (SARP)Blood Institute-sponsored Severe Asthma Research Program (SARP), e1.
58. Pascual RM, Bleecker ER Pharmacogenetics of asthma. Curr Opin Pharmacol 2010, 10:226-235.
59. Lima JJ, Blake KV, Tantisira KG, Weiss ST Pharmacogenetics of asthma. Curr Opin Pulm Med 2009, 15:57-62.
60. 2-agonist therapy in asthma. Eur Respir J 1998, 11:589-593.
61. 2 adrenoceptor polymorphism. Thorax 2000, 55:762-767.
62. 2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet 2007, 370:2118-2125.
63. 2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am J Respir Crit Care Med 2010, 181:676-687.
64. 2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet 2009, 374:1754-1764. for the National Heart, Lung, Blood Institute's Asthma Clinical Research NetworkBlood Institute's Asthma Clinical Research Network.
65. Expert panel report 3: guidelines for the diagnosis and management of asthma 2007, National Asthma Education and Prevention Program, National Heart, Lung, and Blood Institute, Bethesda, (accessed March 13, 2014). https://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
66. Global Strategy for Asthma Management and Prevention 2012 (update) 2012, GINA, Global Initiative for Asthma, (accessed March 13, 2014). http://www.ginasthma.org/local/uploads/files/GINA_Report_March13.pdf.
67. Ortega VE, Hawkins GA, Moore WC, et al. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med 2014, 2:204-213.
68. Himes BE, Jiang X, Hu R, et al. Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene. PLoS Genet 2012, 8:e1002824.
69. Adcock IM, Barnes PJ Molecular mechanisms of corticosteroid resistance. Chest 2008, 134:394-401.
70. Barnes PJ, Adcock IM Glucocorticoid resistance in inflammatory diseases. Lancet 2009, 373:1905-1917.
71. Hawkins GA, Lazarus R, Smith RS, et al. The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. J Allergy Clin Immunol 2009, 123:1376-1383. e7.
72. Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004, 13:1353-1359.
73. Stockmann C, Fassl B, Gaedigk R, et al. Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control. J Pediatr 2013, 162:1222-1227. e1-2.
74. Tantisira KG, Damask A, Szefler SJ, et al. Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus. Am J Respir Crit Care Med 2012, 185:1286-1291. for the SHARP Investigators.
75. Brock TG Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase. J Cell Biochem 2005, 96:1203-1211.
76. Jampilek J, Dolezal M, Opletalova V, Hartl J 5-Lipoxygenase, leukotrienes biosynthesis and potential antileukotrienic agents. Curr Med Chem 2006, 13:117-129.
77. Samuelsson B, Haeggström JZ, Wetterholm A Leukotriene biosynthesis. Ann N Y Acad Sci 1991, 629:89-99.
78. Drazen JM, Yandava CN, Dubé L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999, 22:168-170.
79. Mougey E, Lang JE, Allayee H, et al. ALOX5 polymorphism associates with increased leukotriene production and reduced lung function and asthma control in children with poorly controlled asthma. Clin Exp Allergy 2013, 43:512-520.
80. Kanaoka Y, Maekawa A, Austen KF Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand. J Biol Chem 2013, 288:10967-10972.
81. Austen KF The cysteinyl leukotrienes: where do they come from? What are they? Where are they going?. Nat Immunol 2008, 9:113-115.
82. Slager RE, Otulana BA, Hawkins GA, et al. IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor α antagonist. J Allergy Clin Immunol 2012, 130:516-522. e4.
83. Holgate ST Stratified approaches to the treatment of asthma. Br J Clin Pharmacol 2013, 76:277-291.
84. Steinhausen K From functional genomics to personalised medicine: ten years of an ESF Research Networking Programme. New Biotechnol 2013, 30:276-277.
85. Zieba A, Grannas K, Söderberg O, Gullberg M, Nilsson M, Landegren U Molecular tools for companion diagnostics. New Biotechnol 2012, 29:634-640.
86. Savenije OE, Kerkhof M, Koppelman GH, Postma DS Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol 2012, 130:325-331.
87. Sathish JG, Sethu S, Bielsky MC, et al. Challenges and approaches for the development of safer immunomodulatory biologics. Nat Rev Drug Discov 2013, 12:306-324.
88. Aronson SJ, Clark EH, Varugheese M, Baxter S, Babb LJ, Rehm HL Communicating new knowledge on previously reported genetic variants. Genet Med 2012, 14:713-719.